Anand Murthi

Anand Murthi

Active Director Director DIN 08825783
DIN 08825783 First appointment Aug 2020 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2020
Shareholding value •••• Premium profile

About Anand Murthi

Data last updated:

Anand Murthi is a Director at Doctor's Leaf Pharmaceuticals Private Limited (since 2020). The company operates in Trading. Doctor's Leaf Pharmaceuticals Private Limited reported revenue of ₹81,601 (FY 2023).

DIN 08825783
Primary Designation Director
Industry Trading
First Appointment 07 Aug 2020
Oldest Company Age 6 yrs
Largest company Doctor's Leaf Pharmaceuticals Private Limited · ₹81,601 (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Aug 20202020₹81,601 (FY 2023)Active

Board colleagues of Anand Murthi

Directorship timeline

Open interactive timeline →
Doctor's Leaf Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anand Murthi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anand Murthi

Anand Murthi currently holds 1 directorship: Doctor's Leaf Pharmaceuticals Private Limited (Director, since 07 Aug 2020, revenue ₹81,601 (FY 2023)).

Anand Murthi was first appointed on 07 Aug 2020 as Director at Doctor's Leaf Pharmaceuticals Private Limited.

The current boards of Anand Murthi's companies include Perambalur Ayyadurai Rohith (Doctor's Leaf Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available